Xylem (NYSE: XYL) reported Q1 EPS of $0.35, $0.01 better than the analyst estimate of $0.34. Revenue for the quarter came in at $847 million versus the consensus estimate of $832.92 million.

GUIDANCE:

Xylem sees FY2016 EPS of $1.98-$2.08, versus the consensus of $2.02.

For earnings history and earnings-related data on Xylem (XYL) click here.